Healthcare
Filter News
Found 20,071 articles
-
Over 26 Million Women Have Uterine Fibroids
7/14/2021
It's hard to imagine losing your ability to have children when you're only 30-years-old. But for women who suffer from uterine fibroids, that could be the reality if their doctor recommends they undergo a hysterectomy.
-
Enlivex to Present at the ARDS Drug Development Summit 2021
7/14/2021
Enlivex Therapeutics Ltd., a clinical-stage macrophage reprogramming immunotherapy company, announced that the Company will participate in, and present at, the ARDS Drug Development Summit on Thursday, July 15, 2021.
-
Integra LifeSciences Receives Innovative Technology Contract from Vizient for SurgiMend® Collagen Matrix for Soft Tissue Reconstruction
7/14/2021
Integra LifeSciences Holding Corporation, a leading global medical technology company, announced its SurgiMend® Collagen Matrix for Soft Tissue Reconstruction has received an Innovative Technology contract from Vizient, Inc. the nation’s largest member-driven health care performance improvement company.
-
Tauriga Sciences Inc. Commences Generating Revenue Through Product Sales on Amazon
7/14/2021
Tauriga Sciences, Inc., a New York based diversified Life Sciences Company, announced that it has commenced generating revenue, through product sales on Amazom.com, the world’s largest online retailer.
-
argenx to Host Virtual R&D Day on July 20, 2021
7/14/2021
argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced that it will host a virtual R&D Day on Tuesday, July 20, 2021 at 3:00 p.m. CET to highlight its ‘argenx 2025 vision’ and provide an update of its immunology pipeline.
-
Myovant Sciences to Host First Fiscal Quarter 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on July 28, 2021
7/14/2021
Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced it will host a webcast and conference call to discuss corporate updates and financial results for its first fiscal quarter 2021, ended June 30, 2021.
-
The WHO panel recommends adopting global standards, giving structure to prevent the unscrupulous, inequitable, and possibly dangerous uses of CRISPR technology.
-
The U.S. appears to be beating back COVID-19 but it’s still raging in many parts of the world, and studies and trials are still ongoing. Here’s a look at some of today’s top COVID-19 stories.
-
The data may show the need for one, but vaccine and immunologists are pushing back against Pfizer and BioNTech’s contention that one is necessary now.
-
electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance
7/13/2021
electroCore, Inc., a commercial-stage bioelectronic medicine company, provided an operating and business update as well as select unaudited preliminary financial guidance for the second quarter of 2021.
-
Everest Medicines Announces Strategic Collaboration with Medbanks Health Technology to Develop Innovative Healthcare Service Solutions for Patients in China
7/13/2021
Everest Medicines today announced that it has entered into a strategic collaboration with Medbanks Health Technology, a pharmacy and healthcare services provider specializing in oncology.
-
Genespire appoints Philippe Mauberna as Chief Financial Officer
7/13/2021
Genespire, a next generation gene therapy company developing first-in-class transformative therapies with advanced lentiviral vectors, announces the appointment of Philippe Mauberna, as Chief Financial Officer, effective immediately.
-
NeuroLogica Announces a Research Collaboration with Massachusetts General Hospital to Pilot Photon Counting Computed Tomography at the Patient’s Point-Of-Care Using OmniTom Elite CT
7/13/2021
NeuroLogica Corp. announced that its state-of-the-art, OmniTom Elite with Photon Counting Detector technology will be piloted by Massachusetts General Hospital, bringing multi-energy computed tomography imaging to the patient’s point-of-care.
-
Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, and Quantum Leap Announce Treatment of Severely Ill COVID-19 Patients with Aviptadil in the I-SPY COVID Trial
7/13/2021
RELIEF THERAPEUTICS Holding AG, NRx Pharmaceuticals, Inc., and Quantum Leap Healthcare Collaborative have announced that they have begun treating patients with inhaled aviptadil in the I-SPY COVID Trial, a phase 2 adaptive platform trial aimed at improving treatment for severely and critically ill COVID-19 patients.
-
Nicox Appoints Robert N. Weinreb, M.D. and Sanjay G. Asrani, M.D. to its Glaucoma Clinical Advisory Board
7/13/2021
Nicox SA, an international ophthalmology company, announced that two internationally recognized experts in glaucoma, Robert N. Weinreb, M.D., Distinguished Professor and Chair, Ophthalmology and Director, Shiley Eye Institute, University of California San Diego, and Sanjay G. Asrani, M.D., Professor of Ophthalmology, Duke University, will be joining the Nicox Glaucoma Clinical Advisory Board.
-
Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant
7/12/2021
Texas Biomedical Research Institute and Aridis' data confirmed AR-712 binds to and neutralizes the Delta variant of SARS-CoV-2 virus
-
Veteran AI and ML Leader from LG Electronics and Bosch Joins H1 as SVP of Data Science and Machine Learning
7/12/2021
Dr. Mohak Shah Joins H1 Executive Team to Drive AI Initiatives for the Largest Healthcare Platform Built to Connect Professionals at Hospitals, Life Science Companies and Academic Medical Centers.
-
Aditxt Launches High-Sensitivity Neutralizing Antibody Test to Detect Individual Immune Response to COVID-19
7/12/2021
AditxtScore™ for COVID-19 Now Includes Virus-Specific Infection Blocking Antibodies that Assess the Strength of an Individual’s Immune Response to SARS-CoV-2
-
Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme
7/12/2021
Prothena Corporation plc and Novo Nordisk A/S announced that the companies have entered into a definitive purchase agreement under which Novo Nordisk has acquired Prothena’s clinical stage antibody PRX004 and broader ATTR amyloidosis programme.
-
Lyra Therapeutics to Present at Upcoming Virtual Healthcare Conference
7/12/2021
Lyra Therapeutics, Inc., a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat passages and other diseased tissues, announced that Maria Palasis, Ph.D., Lyra’s President and Chief Executive Officer, will present at the William Blair Biotech Focus Conference on Thursday, July 15, 2021 at 10:00 a.m. ET.